Project Grant HT94252310829
- The Defense Health Agency awarded a $3,150,000 Project Grant to the University of Texas Health Science Center at San Antonio (UTHSCSA) under the Military Medical Research and Development program (CFDA 12.420). The grant supports a randomized clinical trial using noninvasive brain stimulation combined with written exposure therapy for post-traumatic stress disorder (PTSD) in military personnel with mild traumatic brain injury. The project will be performed in San Antonio, TX and runs from...
- The Defense Health Agency has awarded a $1.632 million Project Grant to the Ocean State Research Institute, Inc., a non-profit research organization, to investigate the long-term outcomes of antipsychotic medication use in U.S. veterans with post-traumatic stress disorder (PTSD). This grant, funded through the Military Medical Research and Development program (CFDA 12.420), supports basic, applied, and advanced biomedical research to transform healthcare for service members and the public. As...
- The Defense Health Agency awarded a four-year, $936,532 Cooperative Agreement to the University of Texas Health Science Center at San Antonio (UTHSCSA) to implement and evaluate a patient-centered PTSD treatment program for military personnel. This award is funded under the Military Medical Research and Development (CFDA 12.420) program, which supports biomedical research to transform healthcare for service members and the public. Through this Cooperative Agreement, UTHSCSA will conduct research...
- The Defense Health Agency awarded a $2,788,886 Project Grant to the University of Texas Health Science Center at San Antonio (UTHSCSA) on September 30, 2025 under the Military Medical Research and Development federal grant program (CFDA 12.420). The purpose of this 4-year grant is to support a multisite pilot randomized clinical trial to disseminate the SCIPI (Support, Communication, and Information) program to men with localized prostate cancer. As a prominent Hispanic-serving academic...
- The Defense Health Agency awarded a $2,519,334 Project Grant to The University of Texas Health Science Center at San Antonio (UTHSCSA) to develop and conduct a clinical trial of an AI-facilitated, web-based written exposure therapy training program to increase the reach of evidence-based PTSD treatment. The project falls under the Military Medical Research and Development federal grant program (CFDA 12.420), which supports biomedical research to transform healthcare for military service members,...
- The Defense Health Agency awarded a $3.755 million Project Grant to the University of Wisconsin-Madison through the Military Medical Research and Development program (CFDA 12.420) to investigate dual orexin antagonist treatment to prevent neurobehavioral sequelae of traumatic brain injury from April 1, 2023 to March 31, 2027. The Military Medical Research and Development program supports innovative medical research to improve warfighter health and transform public healthcare. Under this award,...
- The Defense Health Agency awarded a $6,325,327 project grant to the Tampa VA Research and Education Foundation, Inc. under the Military Medical Research and Development program (CFDA 12.420) to improve health care access and engagement for veterans and service members with traumatic brain injury morbidity over a 4-year period ending on September 29, 2027. As the prime grantee, the foundation will provide data identification, extraction, natural language processing, and data transformation...
- The Veterans Medical Research Foundation of San Diego was awarded a $4,802,696 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 1, 2025, supports a four-year research project titled "A HYBRID I EVALUATION OF INTEGRATIVE HEALTH CARE FOR PTSD". The research aims to transform healthcare for military service members, veterans, and the broader public by conducting advanced biomedical...
- The Defense Health Agency awarded a $639,831 Project Grant to the Tampa VA Research and Education Foundation, Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 30, 2025, supports a randomized clinical trial focused on reducing aggression in military personnel. The Tampa VA Research and Education Foundation, a non-profit organization based in Tampa, Florida, will conduct this research initiative, which aims to transform healthcare...
- Veterans Medical Research Foundation Of San Diego will use a $749,985 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to examine associations between traumatic brain injury history and other risk factors on Alzheimer's disease and related dementias in military veterans. As a non-profit organization, the Foundation will leverage its experience conducting medical research to enhance veteran health outcomes. For this award...
The Defense Health Agency awarded a $2.14 million project grant under the Military Medical Research and Development program (CFDA 12.420) to the Foundation For Advancing Veterans Health Research, a non-profit organization and foundation. The funding supports a randomized clinical trial evaluating the effectiveness of quetiapine in reducing polypharmacy among patients with post-concussive syndrome in San Antonio, TX. As a subrecipient, the Foundation also provides staffing, biostatistics, bioinformatics, and research support for clinical trials conducted by the University of Texas Health Science Center at San Antonio, including a trial evaluating responses to aeroallergen challenges before and after receipt of the drug dupilumab. Prior federal subawards supported cancer clinical trials through partners such as Research Triangle Institute, Oregon Health & Science University, and SWOG.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $2.1m | 8/16/23 |